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Abstract
Background: To evaluate changes in H pylori infection prevalence in Greece during a ten-year
period, and to examine its antigenic profile.
Methods: Three groups of patients were studied. Group O-87: Banked serum samples of 200
consecutive adult outpatients, from the Hepato-Gastroenterology clinic of a teaching hospital at
Athens, collected in 1987. Group O-97: Serum samples of 201 similarly selected outpatients from
the same Unit, collected in 1997. Group BD-97: Serum samples of 120 consecutive blood donors
from the same hospital, collected in 1997. H pylori IgG antibody seroprevalence was studied by a
quantitative ELISA. Antigenic profile was studied by western-blot IgG assay, in 62 IgG positive
patients of O-97 and BD-97. Results were analyzed by conventional statistics and multivariate
regression analysis.
Results: The H pylori seroprevalence increased with age in the three tested groups. In O-97,
seroprevalence did not differ from that, in BD-97. On the contrary, there was a significant decrease
in seropositivity between O-87 and O-97 (59.5% vs 49.2%, p = 0.039). Multiple regression analysis
showed that age over 35 years (OR:3.45, 95% CI:1.59–7.49, p = 0.002) and year of patients'
selection – that is 1987 or 1997 – (OR:1.73, 95% CI:1.14–2.65 for 1987, p = 0.010), were
independent risk factors of H pylori infection. The seroprevalence of CagA+ and VacA+ strains was
77.4% and 58.5%, respectively, and type I(CagA+/VacA+) strains were significantly more common
than type II(CagA-/VacA-) strains (59.7% vs 22.6%, p < 0.001).
Conclusions: During a ten-year period, we found a significant decrease of H pylori infection in
Greece and our data support the birth cohort phenomenon as an explanation for the age-
dependent increase of H pylori infection. The prevalence of CagA and/or VacA positive strains is
relatively high, in a country with low incidence of gastric cancer.
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Background
It is known that H pylori infection occurs mainly in early
childhood and the link between the infection and risk fac-
tors such as socioeconomic status and living conditions in
childhood is well documented [1–3]. Thus, there is a
marked difference in the prevalence of H pylori infection
between developing and developed countries during early
childhood [4]. However, everywhere in the world, sero-
logical data have shown that the prevalence of the infec-
tion increases with age [5–7]. In particular in Greece,
according to a study carried out in the early '90s [8] sero-
prevalence increased about 10% per 10 years, from 40%
in people aged 21–40 years to 77% in those older than 60
years.
Long-term follow-up studies in developed countries, with
low rates of H pylori infection, suggest that the age-de-
pendent increase of seropositivity is mainly due to the de-
creasing rate of childhood infections [9–13], since many
studies have proved that during adulthood the rates of se-
roconversion and seroreversion are almost equal
[9,11,14,15]. This phenomenon, is often referred as a
"birth cohort phenomenon". In contrast to this theory,
there is also evidence suggesting that a continuous risk of
acquisition rather than a cohort effect, best explains the
age-dependent increase of seropositivity [16]. However,
in populations with higher rates of infection than that ob-
served in occidental and Scandinavian countries, there are
no data available to evaluate if the cohort phenomenon or
the continuous risk of acquisition could better explain the
age dependent increase of H pylori infection.
Nevertheless, it has been shown that some H pylori genes
(vacA, cagA) confer different biological properties which
could enhance the in vivo pathogenicity of the bacteria
[17,18]. Patients infected with cagA-positive strains of H
pylori demonstrate enhanced expression of various cy-
tokines [19] and these patients present a higher grade of
gastric inflammation and accelerated epithelial damage
[20]. Thus, recently, there has been an interest in detecting
the H pylori immunophenotype and in particular, the
CagA and/or VacA status.
The aim of this study was two-fold: first, to examine the
seroprevalence of H pylori infection in two samples of
Greek adult population that were collected in 1987 and in
1997, that is ten years apart, in order to find out if the
"birth cohort phenomenon" or the continuous risk of ac-
quisition could better explain the age-dependent increase
of H pylori seropositivity, in a country of south-east Eu-
rope with relatively high rate of H pylori infection; and
second, to evaluate the antigenic profile of the H pylori in-
fection (Vag, Cag etc) in a Greek adult population.
Material and Methods
Subjects
The study population included three groups of patients:
Group O-87
Banked serum samples of 200 consecutive adult outpa-
tients, irrespective of their socioeconomic status and the
cause of admission, (107 men and 93 women, aged 15–
82 years, mean age 44.3 +17 years), from Hepatology Sec-
tion of the Gastroenterology clinic of 1st Department of
Propedeutic Medicine (Athens University School of Med-
icine, "Laikon" General Hospital). The used serum sam-
ples were originally obtained in 1987, for the study of
viral hepatitis.
Group O-97
Serum samples of 201 similarly selected outpatients (123
men and 78 women, aged 16–85 years, mean age 45.9
+15.2 years), from the same Section, that were collected in
1997.
Group BD-97
Serum samples of 120 consecutive blood donors from the
same hospital (102 men and 18 women, aged 18–62
years, mean age 40.1 +10.8 years), collected in 1997.
Study design and definition of variables
Group O-97 was compared with group BD-97. Subse-
quently, group O-97 was compared with group O-87. The
analyzed variables were age and gender. Both groups (O-
87 and O-97) comprised of consecutive outpatients from
the same central hospital in Athens. Thus, the demograph-
ic data and the average socioeconomic profile of patients
could be considered roughly similar in both groups, tak-
ing of course into consideration the total development of
the socioeconomic and educational level in our country
during the last decade.
The antigenic profile of the infection was studied in 62
randomly selected H pylori IgG antibody positive patients
of O-97 and BD-97 groups (the first 40 and 22 consecu-
tive H pylori IgG antibody positive samples of O-97 and
BD-97 groups, respectively).
Assays
All serum samples were stored at -70°C and had not been
thawed before the current analysis, except for the samples
of O-87 group which had been thawed once before.
Assay for antibodies to H pylori
H pylori seroprevalence was studied determining IgG an-
tibodies by a quantitative enzyme-linked immunosorbent
assay (ELISA, Diasorin Diagnostics Srl-Manufactured by
Hycor Biomedical GmbH). The antigen used was extract-
ed by sonication from the H pylori strain NTCC 43054.BMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/11
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The main protein fractions which predominantly includ-
ed in H pylori antigen coated to ELISA microtiter plates,
were: p120–130, p83–87, p67, p63/66, p50–59, p28–31,
p19 and p14. These immunogenic proteins were enriched
and purified by a designated developed biochemical pro-
cedure. All assays were performed in duplicate and the in-
tra-assay and inter-assay variations were <5%, as was
estimated with the positive and negative control sera. Val-
idation of the ELISA used, was performed, at the same pe-
riod, in 40 consecutive patients of the Endoscopy Unit of
the same hospital. Using histology (modified Giemsa) as
"gold-standard", the estimated sensitivity, specificity, pos-
itive predictive value (PPV) and negative predictive value
(NPV) of that ELISA were 87%, 94%, 95% and 84%, re-
spectively.
Antigenic profile of H pylori infection
The antigenic profile of the infection was studied using
Immunoblot Helicobacter pylori IgG (Microgen GmbH,
Germany). This test permits the safe identification and lo-
calization of specific antibodies on the solid phase be-
cause the antigens are electrophoretically separated. The
test results were evaluated according to the manufacturer's
instructions and the main detected bands were: p120(Ca-
gA), p87(VacA), p62(UreB), p58(HspA&B), p54(FlaA)
and p29(UreA). Using histology and/or microbiology as
"gold standard", the sensitivity and specificity of this im-
munoblotting test was 95% and 83%, respectively
(Mikrogen molekularbiologische Entwicklungs-Gmbh,
Immunoblot Helicobacter pylori IgG, Instructions for use
version: GIIBHPE004.DOC).
Statistical analysis
Chi-square test was used to test for an association between
H pylori infection and year of patients' selection, by age
group and overall. Multivariate logistic regression was
used to determine risk factors associated with H pylori in-
fection. A model containing all variables was considered.
Variables that did not contribute to the model, based on
their Wald statistic, were eliminated and the new model
was compared to the old through the likelihood ratio sta-
tistic. Variables whose exclusion gave a non-significant
likelihood ratio statistic (p > 0.05) were omitted from the
model.
Results
H pylori seropositivity in O-97 and BD-97 groups (table 1, 
fig. 1)
In 1997, seroprevalence of H pylori infection in all pa-
tients and in the patients' age groups did not differ from
that of blood donors Thus in group BD-97, seropositivity
was 11% up to 24 years, increased of about 136% per dec-
ade up to 44 years and continued to increase at an average
of 13% per decade up to 60 years. In group O-97 seropos-
itivity was 14.2% up to 24 years, increased of about 96%
per decade up to 44 years and continued to increase at an
average of 16.5% per decade up to 64 years.
Prevalence of antibodies in O-87 and O-97 groups of pa-
tients (table 1, figure 1)
The prevalence increased with age in both tested groups of
patients (O-87 and O-97). More specifically, in 1987, the
increase was continuous up to 45–54 years, at an average
rate of 26% per decade. After the age of 55 years, a de-
crease of seropositivity at an average of 10% per decade
was observed.
Table 1: Seroprevalence of H pylori antibodies (IgG) in O-87, O-97 and BD-97 groups.
Age Studied number H pylori IgG(+) (%)
(years) O-87 O-97 BD-97 O-87 O-97 BD-97
15–24 31 21 9 12(38.7) 3(14.2) 1(11.1)
25–34 39 33 30 20(51.3) 12(36.4) 11(36.6)
35–44 31 42 42 21(67.7) 21(50.0) 22(52.4)
45–54 32 43 27 25(78.1)† 23(53.5)† 16(59.2)
55–64 37 43 12 24(64.8) 29(67.4) 8(66.6)
> 65 30 19 – 17(56.7) 11(57.9) –
Total 200 201 120 119(59.5)‡ 99(49.2)‡ 58(48.3)
† p = 0.032, ‡ p = 0.039BMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/11
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In 1997, the prevalence was increasing up to the 55–64
years group, at an average rate of 50% per decade. The av-
erage increasing rate was highest for up to 44 years (96%
per decade) and continued at an average of 16.5% per dec-
ade up to the 55–64 years group. In the oldest age group
(>65 years), a decrease of seropositivity of about 14% per
decade was noticed.
Logistic regression analysis in the group O-87 with inde-
pendent variables such as age and gender, showed that age
over 35 years was the only independent risk factors of H
pylori infection (table 2). Gender was not associated with
positivity, but there was a small but insignificant increase
of seropositivity in males (OR: 1.24, 95% CI: 0.68–2.25,
p = 0.47).
During a ten-year period (1987–1997) the crude H pylori
seroprevalence fell significantly by 10% (from 59.5% in
group O-87, to 49.2% in group O-97, p = 0.039), and it
was constantly lower in each age group (up to 55–64
years) by 15 – 24%.
Logistic regression analysis in all patients (group O-87
and group O-97, 401 patients) with independent varia-
Figure 1
Seroprevalence of H pylori antibodies (IgG) in O-87, O-97 and BD-97 groups.
Table 2: Independent risk factors of H pylori seropositivity in each group of tested patients (O-87, O-97) (multivariate logistic regression 
analysis).
O-87 O-97
Variables Age(years) Odds ratio 95% CI p Odds ratio 95% CI p
15 – 24 1 1
25 – 34 1.68 (0.63, 4.47) 0.29 3.34 (0.81, 13.73) 0.09
35 – 44 3.28 (1.13, 9.49) 0.02 5.54 (1.41, 21.88) 0.01
45 – 54 6.05 (1.96, 18.65) 0.002 7.12 (1.80, 28.07) 0.005
55 – 64 3.28 (1.19, 9.02) 0.02 13.51 (3.35, 54.51) < 0.001
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bles such as age, gender and year of patients' selection
(that is 1987 or 1997), showed that age over 35 years and
the year 1987 were independent risk factors for H pylori
infection (table 3).
The peak of H pylori seroprevalence differs by one decade
in the two tested samples (fig 1). This may suggest that the
risk of infection is associated with the year of patients'
birth. Indeed, in both groups of patients the highest risk
for H pylori seropositivity was found in patients who were
born during the decade 1933–1942 in comparison with
those born after 1953) (table 4).
The antigenic profile of H pylori infection (table 5)
The seroprevalence of CagA and VacA antigens was 77.4%
and 59.7%, respectively. These rates were constant across
gender, age and group of patients (O-97 and BD-97). Type
I (CagA+/VacA+) strains were significantly more common
than type II (CagA-/VacA-) strains (59.7% vs. 22.6%, p <
0.001). The prevalence of the other antigens ranged from
33.9% (FlaA) to 82.2% (UreB).
Discussion
Our findings show that the prevalence of H pylori IgG an-
tibodies increases with age in the three tested groups of
patients (O-87, O-97 and BD-97). Provided that the ELISA
used had 87% sensitivity and 94% specificity, the results
reflect satisfactorily H pylori infection rate. H pylori sero-
prevalence did not differ between the group O-97 and the
healthy controls (group BD-97)(49.2% vs 48.3%, respec-
tively, p = 0.87). On the contrary, comparing the group O-
87 with the group O-97, we found a significant decrease
of the infection rate in 1997 (59.5% vs 49.2%, respective-
ly, p = 0.039).
The dynamic of infection in 1987 seems to be similar with
that seen in the developing countries. Ten years later, in
1997, the picture changed toward what was found in the
developed countries. Thus, the crude seroprevalence was
reduced about 10% units; multiple regression analysis
showed that a person of the O-87 group had a significant
higher risk of seropositivity than a comparable person of
the O-97 group (OR:1.73, 95% CI: 1.14–2.65, p = 0.010).
As we did not found paired serum samples of the same pa-
tient in groups O-87 and O-97 we could not know the rate
of serocorversion in our population. But, in both develop-
ing and developed countries, there are many studies sug-
gesting that, during adulthood, the rate of seroconversion
and seroreversion is almost the same[9,14,15]. Thus,
though our data showed that increasing age does increase
the risk of H pylori infection, the fact that patients from
group O-87 had higher rates of infection than comparable
patients from group O-97, supports the "birth cohort phe-
nomenon" as the main cause for the increasing occurrence
of the infection seen with age.
Table 3: Independent risk factors of H pylori seropositivity in O-
87 and O-97 groups of patients (N:401) (multivariate logistic re-
gression analysis).
Variables Age(years) Odds ratio 95% CI p
15 – 24 1
25 – 34 2.02 (0.94, 4.37) 0.073
35 – 44 3.45 (1.59, 7.49) 0.002
45 – 54 5.07 (2.31, 11.11) < 0.001
55 – 64 5.60 (2.57, 12.19) < 0.001
> 65 3.49 (1.51, 8.10) 0.004
Period
1997 1
1987 1.73 (1.14, 2.65) 0.010
Table 4: Decade of birth as an independent risk factor of H pylori seropositivity (multivariate logistic regression analysis).
1987 1997
Year of patients' birth Odds ratio 95% CI p Odds ratio 95% CI p
> 1953 1 1
1943–1952 2.49 1.01 – 6.14 0.047 2.08 1.00 – 4.34 0.050
1933–1942 4.54 1.71 – 12.03 0.002 3.57 1.67 – 7.62 0.001
1923–1932 2.47 1.07 – 5.73 0.035 2.87 0.96 – 8.56 0.058
< 1923 1.69 0.70 – 4.06 0.24 2.08 0.10 – 28.38 0.704BMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/11
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The highest risk of infection in both groups of patients,
was found in those born around 1940, that is the period
of war deprivation. This finding, in association with the
reduction in the infection rate during the studied 10-year
period is compatible with the hypothesis that better soci-
oeconomic conditions and improved hygiene have re-
duced the risk of H pylori infection [4].
In both groups of patients (O-87 and O-97) we found a
constant decrease of seropositivity in the oldest age group.
This may be due to many factors like spontaneous serore-
version [14], increased antibiotics and NSAIDs consump-
tion [21] and advanced gastric atrophy in association with
the natural senility of the immunological system [22].
In this study the prevalence of CagA positive and VacA
positive strains of H pylori were 77.4% and 59.7%, respec-
tively; type I strains were significantly more common than
type II strains (59.7% vs. 22.6%, p < 0.001). According to
the Eurogast study group, Greece has low incidence of gas-
tric cancer in comparison with other European countries
[23]. It has been suggested that CagA positive infections
are more likely to predispose to gastric cancer that the
CagA negative ones [24]. Nevertheless, we found a high
rate of CagA positive and type I strains of H pylori in our
sample. In accordance with previous studies [20,25,26],
these data suggest that CagA and/or VacA status are not
the only factors that influence gastric cancer rates.
To conclude, a significant decrease of H pylori infections'
rate was noticed in Greece during a ten-year period. Even
in a country of south-east Europe, with relatively high rate
of H pylori infection, our data support the birth cohort
phenomenon as an explanation for the age-dependent in-
crease of H pylori infection. The prevalence of CagA and/
or VacA positive strains is relatively high for the reported
incidence of gastric cancer in Greece.
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